Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1

Genes and Development

Volumn 24, Issue 3, 2010, Pages 256-264

  Sabio, Guadalupe ^a,c   Cavanagh Kyros, Julie ^a   Barrett, Tamera ^a   Jung, Dae Young ^a,b   Ko, Hwi Jin ^a,b   Ong, Helena ^a   Morel, Caroline ^a   Mora, Alfonso ^a   Reilly, Judith ^a   Kim, Jason K ^a,b   Davis, Roger J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c CSIC   (Spain)

Author keywords

Insulin resistance; JNK1; Obesity; Thyroid hormone

Indexed keywords

AGOUTI RELATED PROTEIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GONADORELIN; GROWTH HORMONE; LEPTIN RECEPTOR; PROOPIOMELANOCORTIN; SOMATOSTATIN; STRESS ACTIVATED PROTEIN KINASE 1; THYROID HORMONE; THYROTROPIN BETA SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; DIET; ENERGY EXPENDITURE; GERM LINE; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; METABOLIC REGULATION; MOUSE; NERVOUS SYSTEM; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

MURINAE;

EID: 76149090834     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1878510     Document Type: Article

References (24)

1. 2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054.
2. Bennett BL, Satoh Y, Lewis AJ. 2003. JNK: A new therapeutic target for diabetes. Curr Opin Pharmacol 3: 420-425.
3. Björkman U, Ekholm R. 2000. Biochemistry of thyroid hormone formation and secretion. In The thyroid gland (ed. Greer MA), pp. 83-125. Raven Press, New York.
4. Das M, Jiang F, Sluss HK, Zhang C, Shokat KM, Flavell RA, Davis RJ. 2007. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc Natl Acad Sci 104: 15759-15764.
5. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA. 1998. Defective T cell differentiation in the absence of Jnk1. Science 282: 2092-2095.
6. Dor Y, Brown J, Martinez OI, Melton DA. 2004. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429: 41-46.
7. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. 2002. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336.
8. Kahn SE, Hull RL, Utzschneider KM. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846.
9. Kaneto H, Nakatani Y, Miyatsuka T, Kawamori D, Matsuoka TA, Matsuhisa M, Kajimoto Y, Ichijo H, Yamasaki Y, Hori M. 2004. Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat Med 10: 1128-1132.
10. Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB, et al. 2004. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53: 1060-1067.
11. Lee YH, Giraud J, Davis RJ, White MF. 2003. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 278: 2896-2902.
12. Lenard NR, Berthoud HR. 2008. Central and peripheral regulation of food intake and physical activity: Pathways and genes. Obesity (Silver Spring) 16: S11-S22. doi: 10.1038/ oby.2008.511.
13. Mangada J, Pearson T, Brehm MA, Wicker LS, Peterson LB, Shultz LD, Serreze DV, Rossini AA, Greiner DL. 2009. Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice. Diabetes 58: 165-173.
14. Mora A, Sakamoto K, McManus EJ, Alessi DR. 2005. Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart. FEBS Lett 579: 3632-3638.
15. Myers MG Jr, Munzberg H, Leinninger GM, Leshan RL. 2009. The geometry of leptin action in the brain: More complicated than a simple ARC. Cell Metab 9: 117-123.
16. Obregon MJ. 2008. Thyroid hormone and adipocyte differentiation. Thyroid 18: 185-195.
17. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK, Davis RJ. 2008. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322: 1539-1543.
18. Sabio G, Cavanagh-Kyros J, Ko HJ, Jung DY, Gray S, Jun JY, Barrett T, Mora A, Kim JK, Davis RJ. 2009. Prevention of steatosis by hepatic JNK1. Cell Metab 10: 491-498.
19. Sabio G, Cavanagh-Kyros J, Ko HJ, Jung DY, Gray S, Jun JY, Barrett T, Kim JK, Davis RJ. 2010. Role of muscle JNK1 in obesity-induced insulin resistance. Mol Cell Biol. 30: 106-115.
20. Stebbins JL, De SK, Machleidt T, Becattini B, Vazquez J, Kuntzen C, Chen LH, Cellitti JF, Riel-Mehan M, Emdadi A, et al. 2008. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc Natl Acad Sci 105: 16809-16813.
21. Townsend KL, Lorenzi MM, Widmaier EP. 2008. High-fat dietinduced changes in body mass and hypothalamic gene expression in wild-type and leptin-deficient mice. Endocrine 33: 176-188.
22. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schutz G. 1999. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23: 99-103.
23. Weston CR, Davis RJ. 2007. The JNK signal transduction pathway. Curr Opin Cell Biol 19: 142-149.
24. Whitmarsh AJ, Davis RJ. 2001. Analyzing JNK and p38 mitogenactivated protein kinase activity. Methods Enzymol 332: 319-336.